Xvivo
Manufacturing · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
PO Box, Goeteborg, Vaestra Goetaland, 40...Phone Number
+46 317882150Website
www.xvivoperfusion.comRevenue
$28.3 MillionIndustry
About Xvivo
Is Xvivo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Xvivo has new funding data
Congratulate Masked Content for being promoted to Masked Content at Xvivo
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Xvivo recently announced quarterly report
Click to see if Xvivo had a recent Job posting/layoffs
Xvivo, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Xvivo has recently received funding, and reach out quickly before it becomes old news!
Check out if Xvivo is spiking on competitors!
Product Launch: Get notified when Xvivo launches new products
Recommended Actions
Find VP level buyers at Xvivo
Find 2 more new buyers
Company Profile Activity
Activity Insights
Xvivo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xvivo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xvivo.
Xvivo Tech Stack
A closer look at the technologies used by Xvivo
Xvivo News & Media
Nomination Committee of XVIVO Perfusion AB (publ)
XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO Granted Breakthrough Device Designation from the FDA for the Liver Assist Device
XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for their Liver Assist device, indicated for ex-vivo oxygenated machine perfusion for preservation of donor livers prior to transplantation.Change in Number of Shares and Votes in XVIVO Perfusion
GOTHENBURG, SWEDEN / ACCESSWIRE / June 30, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The number of shares and votes in XVIVO Perfusion AB (publ) has during June 2022 increased by 63,301 shares and votes as a result of warrants being exercised as part of the company's 2020 incentive program. As of June 30, 2022 there are thus in total 29,561,967 shares and votes in the company.Reimbursement Established for Lung and Liver Transplant in the Netherlands Based on Results from Clinical Trials with XVIVO's Leading Technologies
GOTHENBURG, SE / ACCESSWIRE / May 12, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Machine perfusion for lungs and livers is now being reimbursed in the Dutch healthcare system. The Netherlands has a pronounced evidence-based healthcare system.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xvivo
Xvivo Ab is a company that operates in the Medical Devices & Equipment industry. It employs 50to99 people and has 25Mto50M of revenue. The company is headquartered in Goeteborg, Vaestra Goetaland, Sweden.... Read More